Reliance II is a phase III trial designed to evaluate REL-1017 as an adjunctive treatment for major depressive disorder (MDD), to be used in combination with other approved anti-depressants.

Here is the situation on Saturday, December 7: A Russian attack on the southern city of Zaporizhzhia killed at least 10 people and wounded 24 on Friday. The city’s governor, Ivan Fedorov, said ...

快科技12月2日消息，领克汽车宣布中大型轿车领克Z10 95kWh 702km四驱Halo版正式上市，售价22.98万元。 据悉，此次发布的新车型介于后驱智驾Max和四驱智 ...

快科技12月4日消息，今日，华为Mate 70系列开启首销，售价5499元起。 今晚，抖音博主“杨长顺维修家”发布华为Mate 70拆机视频，麒麟9010再次现身。